Categories: Market

IMS Health’s market reflection report for June 2016

New Delhi, July 18, 2016

Some of the key highlights are:

– The IPM grew at 13% as of on MAT June 2016

– The IPM was valued at Rs. 107,019 crores and the retail sector was valued at Rs.89,784 crores as of MAT June 2016

– All therapies have seen a dip since February 2016. However, GI (Gastro Intestinal) has shown a growth in June 2016 over May 2016

– Respiratory is the largest affected market by the ban with 71% of the value of banned drugs being contributed by 6 molecule combinations. However, Dextromethorphan + Chlorpheniramine combinations and Bromhexine combinations have shown improved growth in June 2016

Corporate Comm India(CCI Newswire)

The Pharma Times News Bureau

Recent Posts

Lung Cancer Awareness Month

By Dr. C N Patil, HOD and Lead Consultant - Medical Oncology & Haemato-Oncology, Aster…

22 hours ago

Unmasking COPD: The Silent Respiratory Threat of Smoking

By  Dr. Pavan Yadav, Lead Consultant - Interventional Pulmonology & Lung Transplantation, Aster RV Hospital …

22 hours ago

Khazi India Foundation to Host Expert Cardiac Consultations in Adoni

Kurnool, November 20, 2024: Adoni, Andhra Pradesh, – The Khazi India Foundation is pleased to…

2 days ago

Aakash Healthcare Celebrates Children’s Day with Kids from Choti Si Khushi

New Delhi, November 20, 2024: Aakash Healthcare marked this year’s Children’s Day with a joyful…

2 days ago

Annual eye screening crucial for diabetic patients to protect eyesight: Dr Agarwals Eye Hospital

Dr Agarwals Eye Hospital, Bengaluru, is providing free consultations for diabetic patients aged 50 and…

4 days ago

7 Signs You Are Suffering From Protein Deficiency

By Ms. Archana S, Senior Nutritionist, Aster Whitefield Hospital, Bengaluru As an essential nutrient, protein…

4 days ago